Human mobilised peripheral blood, Leukopak

Lieferant: HemaCare
M001F-GCSF-2EA 0 EUR
M001F-GCSF-2 M001F-GCSF-3 M001F-GCSF-4 M001F-GCSFMOZ2 M001F-MOZ-1 M001F-GCSFMOZ1
Human mobilised peripheral blood, Leukopak
Zellen
A Leukopak is an enriched leukapheresis product collected from normal peripheral blood. It is composed of a variety of blood cells including monocytes, lymphocytes, platelets, plasma, and red cells. A leukopak contains a higher concentration of cells as compared to standard venipuncture collection methods or buffy coat products.

  • Test negative for Hepatitis B, C, HIV, HTLV, HCV/HBV, WNV, Trypanasoma cruzi, and Syphilis

Leukopaks from mobilised peripheral blood are collected from healthy human donors under IRB approved informed consent by leukapheresis using the COBE® Spectra or Spectra Optia® Apheresis System MNC collection protocol. Donors are injected with a combination of Mozobil® and G-CSF (Neupogen® - FDA approved), which stimulates the bone marrow to produce a large number of hematopoietic and progenitor stem cells and mobilises them into the peripheral blood stream. Mozobil® alone and G-CSF only protocols are also available. This mononuclear cell-rich leukapheresis product is extracted using continuous flow centrifugal technology directly into the collection bag.

Storage: Use immediately upon receipt.

Bitte beachten Intended for research use only and not for direct therapeutic or diagnostic use in human or animals, or for further manufacturing of therapeutic products or devices.
Bestellen

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR